Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Share-based Compensation (2014 - 2026)

Ocugen's (OCGN) quarterly Share-based Compensation came in at $3.4 million in Q1 2026, up 80.27% YoY from $1.9 million in Q1 2025, and up 358.21% on a QoQ basis from -$1.3 million in Q4 2025.

Analysis

Ocugen (OCGN) Share-based Compensation (2014 - 2026) Analysis & Trends

Ocugen (OCGN) has 13 years of Share-based Compensation data on file, last reported at $3.4 million in Q1 2026.

  • Quarterly Share-based Compensation rose 80.27% year-over-year to $3.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.2 million (down 21.45% YoY) and the FY2024 annual result came in at $1.0 million, down 89.15% from the prior year.
  • Share-based Compensation grew to $3.4 million in Q1 2026, from -$1.3 million in the prior quarter.
  • In the past five years, Share-based Compensation ranged from a high of $3.4 million in Q1 2026 to a low of -$1.3 million in Q4 2025.
  • A 5-year average of $2.0 million and a median of $2.0 million in 2025 frame the typical range for Share-based Compensation.
  • Annual changes were most pronounced in 2022 — Share-based Compensation surged 296.04% — and 2025, when it sank 246.71%.
  • Tracing OCGN's Share-based Compensation over 5 years: stood at $2.7 million in 2022, then sank by 35.46% to $1.7 million in 2023, then sank by 47.91% to $897000.0 in 2024, then slumped by 246.71% to -$1.3 million in 2025, then soared by 358.21% to $3.4 million in 2026.
  • The last three Share-based Compensation figures came in at $3.4 million (Q1 2026), -$1.3 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 108.10 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 243.00 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 120.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 277.20 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 137.41 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 86.63 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 41.25 Mn
10 Ocugen 458.91 Mn 358.81 Mn - 1.83 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.83 Mn
Mar 31, 2026 3.40 Mn
Dec 31, 2025 2.00 Mn
Sep 30, 2025 1.98 Mn
Jun 30, 2025 1.85 Mn
Mar 31, 2025 1.89 Mn
Dec 31, 2024 1.88 Mn
Sep 30, 2024 1.89 Mn
Jun 30, 2024 1.90 Mn
Mar 31, 2024 1.76 Mn
Dec 31, 2023 1.72 Mn
Sep 30, 2023 2.17 Mn
Jun 30, 2023 2.63 Mn
Mar 31, 2023 2.69 Mn
Dec 31, 2022 2.67 Mn
Sep 30, 2022 2.50 Mn
Jun 30, 2022 2.08 Mn
Mar 31, 2022 3.30 Mn
Dec 31, 2021 2.68 Mn
Sep 30, 2021 1.35 Mn